Mark A. Rubin , M.D. was the Founding Director of the Englander Institute for Precision Medicine, a recognized thought leader in the area of prostate cancer genomics and pathology. As a board-certified pathologist with expertise in prostate cancer pathology and the translation of novel findings to clinical investigations and a laboratory-based researcher, Dr. Rubin has more than 16 years experience in biomarker discovery and characterization. He is now based in Bern at the Department for BioMedical Research (DBMR), University of Bern, Switzerland.